Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazoprevir/Elbasvir for HCV Genotype 4 Post Kidney Transplant
NCT03359746Phase 4Unknown
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of grazoprevir, elbasvir in hepatitis C (HCV), sponsored by King Faisal Specialist Hospital and Research Centre. Status: unknown.
02
Drugs
grazoprevirelbasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03359746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359746.